A detailed history of Raymond James Financial Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 2,028,212 shares of EW stock, worth $175 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,028,212
Previous 2,080,872 2.53%
Holding current value
$175 Million
Previous $163 Million 3.08%
% of portfolio
0.05%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$73.75 - $81.83 $3.88 Million - $4.31 Million
-52,660 Reduced 2.53%
2,028,212 $158 Million
Q2 2025

Aug 14, 2025

SELL
$67.07 - $78.22 $6.78 Million - $7.91 Million
-101,083 Reduced 4.63%
2,080,872 $163 Million
Q1 2025

May 13, 2025

SELL
$67.95 - $76.19 $48 Million - $53.8 Million
-706,653 Reduced 24.46%
2,181,955 $158 Million
Q4 2024

Feb 06, 2025

BUY
$64.54 - $75.92 $186 Million - $219 Million
2,888,608 New
2,888,608 $214 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.